Rarity is a biotechnology company that offers genetic treatments for immune diseases.
Rarity has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Rarity's investors include Steve Oliveira.
Rarity is headquartered in Los Angeles, United States.
Rarity is a biotechnology company that offers genetic treatments for immune diseases.
Rarity is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rarity — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/rarity. Accessed August 14, 2026.
VCBacked. (2025). Rarity — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rarity
{{cite web |title=Rarity — Funding & Investors |url=https://www.vcbacked.co/company/rarity |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated